SINGULAR GENOMICS SYSTEMS IN (OMIC)
US82933R1005 - Common Stock
ChartMill assigns a Buy % Consensus number of 78% to OMIC. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 0.69. This target is 76.54% above the current price.
OMIC was analyzed by 9 analysts. The buy percentage consensus is at 78. So analysts seem to be have mildly positive about OMIC.
In the previous month the buy percentage consensus was at a similar level.
OMIC was analyzed by 9 analysts. More opinions would make the average more meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2024-03-20 | UBS | Maintains | Neutral -> Neutral |
| 2024-01-23 | Goldman Sachs | Maintains | Neutral -> Neutral |
| 2024-01-22 | Goldman Sachs | Maintains | Neutral -> Neutral |
| 2023-08-10 | Goldman Sachs | Maintains | Neutral -> Neutral |
| 2022-11-08 | Goldman Sachs | Maintains | Neutral |
| 2022-08-17 | UBS | Downgrade | Buy -> Neutral |
| 2022-08-10 | Goldman Sachs | Downgrade | Buy -> Neutral |
| 2022-08-10 | B of A Securities | Downgrade | Buy -> Underperform |
| 2022-07-14 | Goldman Sachs | Maintains | Buy |
| 2022-05-11 | Goldman Sachs | Maintains | Buy |
| 2022-04-13 | Goldman Sachs | Maintains | Buy |
| 2022-01-07 | B of A Securities | Upgrade | Neutral -> Buy |
| 2021-06-21 | Cowen & Co. | Initiate | Outperform |
| 2021-06-21 | JP Morgan | Initiate | Overweight |
| 2021-06-21 | Goldman Sachs | Initiate | Buy |
| 2021-06-21 | B of A Securities | Initiate | Neutral |